Aastrom Biosciences Inc: Stock Rating SummaryAastrom Biosciences Inc, a small-cap company in the health care sector, is expected to significantly underperform the market over the next six months with very high risk.
10 is the best possible rating.
Quick SummaryDetails ProEarnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. PositiveConThe price-to-earnings multiple is a negative number. No effectThe StockScouter measure of relative price change and consistency is very low. Very negativeShares are being heavily sold by financial institutions. Neutral for a small company like ASTM
Me thinks you are trying to hold the entry point for monday........are you? It appears you have no position and hoping to rain on a parade long enough to get in. Your theory holds no water with current news hitting the streets.